Female mice exhibit exacerbated anhedonia and 3-fold more hippocampal gene changes than males after stress
Background
Major depressive disorder (MDD) disproportionately affects women, yet the specific cellular and molecular mechanisms driving this sex disparity remain poorly understood. Current treatments often lack sex-specific efficacy, highlighting a critical gap in understanding how stress impacts the brain differently in males and females. The hippocampus, a brain region crucial for mood regulation and stress response, is a key area for investigating these sex-specific molecular adaptations. Unraveling these differences could lead to more targeted and effective therapies for stress-related psychiatric conditions.
Study Design
Researchers exposed male and female C57BL/6N mice to sub-chronic variable stress (SCVS) to model chronic stress. Anhedonia, a core symptom of depression, was quantified using sucrose preference and novelty-suppressed feeding tests. To map sex-specific molecular responses, single-nucleus RNA sequencing (snRNA-seq) was performed on 31,256 hippocampal cells, comparing transcriptional profiles between stressed males and females. Plasma serotonin (5-HT) levels were also measured to assess neurochemical changes.
Results
Female mice exhibited significantly exacerbated anhedonia and selective depletion of plasma serotonin (5-HT) following SCVS exposure, contrasting with minimal behavioral changes in males. Single-nucleus RNA sequencing of 31,256 hippocampal cells revealed profound sex-dimorphic transcriptional reprogramming: females showed a 3-fold greater number of differentially expressed genes (DEGs) than males, with minimal overlap in gene sets. Key mechanistic findings included:
Females displayed oligodendrocyte-specific upregulation of mitochondrial genes (
mt-Atp6,mt-Co3), increasing oxidative stress susceptibility, alongside a stress-induced depletion of baseline oligodendrocyte predominance, potentially disrupting hippocampal synchrony underlying anhedonia. Females also exhibited broadMef2cupregulation, while males showed astrocyte/cholinergic neuronNRG-1upregulation and astrocyteSlc6a11downregulation. Furthermore, females displayed suppressed oxytocin signaling and coordinated dampening of glutamatergic signaling, astrocyticK+buffering, and cell adhesion, whereas males exhibited dysregulated kinase/phosphatase activity.
Key Findings
- Female mice developed significantly exacerbated anhedonia after SCVS, unlike males.
- Plasma serotonin (5-HT) was selectively depleted in stressed female mice.
- Females exhibited a 3-fold greater number of differentially expressed genes in the hippocampus than males.
- Female mice showed oligodendrocyte-specific upregulation of mitochondrial genes (
mt-Atp6,mt-Co3). - Oxytocin signaling and glutamatergic signaling were suppressed in females.
Why It Matters
This study provides a foundational single-nucleus atlas of sex-specific hippocampal stress responses, highlighting distinct molecular vulnerabilities in females. Understanding these sex-dimorphic mechanisms is crucial for developing personalized therapeutic strategies for MDD and other stress-related disorders. The identification of oligodendrocyte mitochondrial dysfunction, Mef2c upregulation, and oxytocin suppression in females points to novel, sex-specific targets for drug development. This research suggests that treatments effective in males may not translate to females, emphasizing the need for sex-informed preclinical and clinical research to advance precision psychiatry. While preclinical, these findings lay the groundwork for future investigations into sex-specific interventions.
major depressive disorder
stress
sex differences
hippocampus
single-nucleus rna sequencing
anhedonia